নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

novartis norge as - deksametason - Øyedråper, suspensjon - 1 mg/ ml

সুইডেন - সুইডিশ - Läkemedelsverket (Medical Products Agency)

novartis sverige ab - dexametason - Ögondroppar, suspension - 1 mg/ml - dexametason 1 mg aktiv substans; bensalkoniumklorid hjälpämne - dexametason

সুইডেন - সুইডিশ - Läkemedelsverket (Medical Products Agency)

2care4 aps - dexametason - Ögondroppar, suspension - 1 mg/ml - dexametason 1 mg aktiv substans; bensalkoniumklorid hjälpämne - dexametason

সুইডেন - সুইডিশ - Läkemedelsverket (Medical Products Agency)

2care4 aps - dexametason - Ögondroppar, suspension - 1 mg/ml - dexametason 1 mg aktiv substans; bensalkoniumklorid hjälpämne - dexametason

সুইডেন - সুইডিশ - Läkemedelsverket (Medical Products Agency)

paranova läkemedel ab - dexametason - Ögondroppar, suspension - 1 mg/ml - bensalkoniumklorid hjälpämne; dexametason 1 mg aktiv substans

স্পেন - স্পেনীয় - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

industrial farmaceutica cantabria s.a. - minoxidil - soluciÓn cutÁnea - 20 mg/ml - minoxidil 20 mg - minoxidil

স্পেন - স্পেনীয় - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

industrial farmaceutica cantabria s.a. - minoxidil - soluciÓn cutÁnea - 50 mg/ml - minoxidil 50 mg - minoxidil

সারবিয়া - সার্বীয় - Агенција за лекове и медицинска средства Србије (Agencija za lekove i medicins)

predstavniŠtvo novartis pharma services inc. beograd (novi beograd) - дексаметазон - kapi za oči, suspenzija - 1mg/ml

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

dexamethasone -

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - dexamethasone, quantity: 1 mg/ml - eye drops, suspension - excipient ingredients: dibasic sodium phosphate; polysorbate 80; disodium edetate; sodium chloride; benzalkonium chloride; purified water; hypromellose; citric acid monohydrate; sodium hydroxide - indications as at 16 jan 2005 : steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe, such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitis when the inherent hazard of steroid use is accepted to obtain an advisable diminution in oedema and inflammation; acute and chronic anterior uveitis; corneal injury from chemical radiation or thermal burns or penetration of foreign bodies.